ATE387213T1 - Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden - Google Patents

Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden

Info

Publication number
ATE387213T1
ATE387213T1 AT01922220T AT01922220T ATE387213T1 AT E387213 T1 ATE387213 T1 AT E387213T1 AT 01922220 T AT01922220 T AT 01922220T AT 01922220 T AT01922220 T AT 01922220T AT E387213 T1 ATE387213 T1 AT E387213T1
Authority
AT
Austria
Prior art keywords
activity against
substances
discomforts
oxytocin activity
against climacteric
Prior art date
Application number
AT01922220T
Other languages
English (en)
Inventor
Kerstin Uvnaes-Moberg
Thomas Lundeberg
Original Assignee
Entretech Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entretech Medical Ab filed Critical Entretech Medical Ab
Application granted granted Critical
Publication of ATE387213T1 publication Critical patent/ATE387213T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01922220T 2000-04-18 2001-04-18 Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden ATE387213T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001440A SE0001440D0 (sv) 2000-04-18 2000-04-18 A drug against climacteric disorders

Publications (1)

Publication Number Publication Date
ATE387213T1 true ATE387213T1 (de) 2008-03-15

Family

ID=20279369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01922220T ATE387213T1 (de) 2000-04-18 2001-04-18 Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden

Country Status (8)

Country Link
US (2) US20040029787A1 (de)
EP (1) EP1406649B9 (de)
AT (1) ATE387213T1 (de)
AU (1) AU2001248994A1 (de)
DE (1) DE60133050T2 (de)
ES (1) ES2302728T3 (de)
SE (1) SE0001440D0 (de)
WO (1) WO2001078758A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100684D0 (sv) 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
US8883965B2 (en) 2006-02-10 2014-11-11 Ferring B.V. Compounds
US9050286B2 (en) 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists
CA2698768A1 (en) * 2007-09-11 2009-04-02 Dorian Bevec Use of a peptide as a therapeutic agent
WO2009039973A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of peptide arg-asn-ile-ala-glu-ile-ile-lys-asp-ile-oh or its combination with the peptide asp-arg-gly-asp-ser-oh as a therapeutic agent
WO2009033724A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of c-type natriuretic peptide, alone or incombination with neuropeptide af, as a therapeutic agent
WO2009033731A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a laminin peptide as a therapeutic agent
WO2009033820A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
WO2014057092A1 (en) * 2012-10-12 2014-04-17 Pep-Tonic Medical Ab Novel use of a composition comprising oxytocin
SE1750680A1 (en) 2017-05-30 2018-12-01 Peptonic Medical Ab Composition for treating or preventing climacteric disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889844A (en) * 1985-10-22 1989-12-26 Silvetti Sr Anthony N Fructose containing wound healing preparation
CA2110176A1 (en) * 1992-03-28 1993-10-14 Akira Yanagawa Topical preparation for healing wounds of the skin
MY117988A (en) * 1995-10-03 2004-08-30 Nor Ind Inc Cleaning compositions for oil and gas well, lines, casings, formations and equipment and methods of use
US5753266A (en) * 1996-12-03 1998-05-19 Youssefyeh; Parvin Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
SE9803272D0 (sv) * 1998-09-25 1998-09-25 Kerstin Uvnaes Moberg A drug for cell regeneration
US6333313B1 (en) * 1998-10-29 2001-12-25 Board Of Regents, The University Of Texas System Clinical use of oxytocin alone or in combination to treat bone disorders
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter

Also Published As

Publication number Publication date
AU2001248994A1 (en) 2001-10-30
SE0001440D0 (sv) 2000-04-18
EP1406649A1 (de) 2004-04-14
ES2302728T3 (es) 2008-08-01
US20040029787A1 (en) 2004-02-12
DE60133050D1 (de) 2008-04-10
DE60133050T2 (de) 2009-02-26
EP1406649B9 (de) 2008-10-15
US20060148685A1 (en) 2006-07-06
US7727959B2 (en) 2010-06-01
EP1406649B1 (de) 2008-02-27
WO2001078758A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
WO2004089396A3 (en) Anti-fungal peptidomimetics
ATE387213T1 (de) Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden
NO20025450L (no) Ny farmasöytisk sammensetning
IL181689A0 (en) Aptamers to von willebrand factor and pharmaceutical compositions containing the same
DK1501534T5 (da) Desmopressin i orodispergerbar dosisform
TR200100149T2 (tr) Dual anjiyotensin endotelin alıcı antagonistleri olarak bifenil-sülfonamitler
ITTO20000779A0 (it) Composizioni farmaceutiche.
DE60140540D1 (de) Flügelstabilisiertes geschoss
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
ATE348617T1 (de) Heilmittel gegen durch endothelin verursachte erkrankungen
ATE309339T1 (de) Thrombomodulin analoga und ihre pharmazeutische verwendung
ATE251614T1 (de) Piperazinderivate als neurokinin-antagonisten
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
DE60231611D1 (de) Verabreichung von opioiden durch inhalation
SE9803272D0 (sv) A drug for cell regeneration
ATE266722T1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
SE0102910D0 (sv) New use
DE50309381D1 (de) Neue pyrimidin-4,6-dicarbons urediamide zur selektiven inhibierung von kollagenasen
DE602004016752D1 (de) Kombination enthaltend substanzen mit npy-rezeptor affinität und substanzen mit 5-ht6-rezeptor affinität
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure
ITFI20050178A1 (it) Uso di metalloproteinasi di matrice, mutate e non, per la preparazione di composizioni farmaceutiche, e metalloproteinasi mutate aventi aumentata stabilita'
DE60224280D1 (de) Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis
SE0103476D0 (sv) New use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1406649

Country of ref document: EP